266 related articles for article (PubMed ID: 29300491)
1. "Clicking" Gene Therapeutics: A Successful Union of Chemistry and Biomedicine for New Solutions.
Astakhova K; Ray R; Taskova M; Uhd J; Carstens A; Morris K
Mol Pharm; 2018 Aug; 15(8):2892-2899. PubMed ID: 29300491
[TBL] [Abstract][Full Text] [Related]
2. Lipidic carriers of RNA/DNA oligonucleotides and polynucleotides: what a difference a formulation makes!
Keller M
J Control Release; 2005 Apr; 103(3):537-40. PubMed ID: 15820402
[No Abstract] [Full Text] [Related]
3. Delivery of oligonucleotides with lipid nanoparticles.
Wang Y; Miao L; Satterlee A; Huang L
Adv Drug Deliv Rev; 2015 Jun; 87():68-80. PubMed ID: 25733311
[TBL] [Abstract][Full Text] [Related]
4. New Formulation for the Delivery of Oligonucleotides Using "Clickable" siRNA-Polyisoprenoid-Conjugated Nanoparticles: Application to Cancers Harboring Fusion Oncogenes.
Massaad-Massade L; Boutary S; Caillaud M; Gracia C; Parola B; Gnaouiya SB; Stella B; Arpicco S; Buchy E; Desmaële D; Couvreur P; Urbinati G
Bioconjug Chem; 2018 Jun; 29(6):1961-1972. PubMed ID: 29727181
[TBL] [Abstract][Full Text] [Related]
5. Antisense Oligonucleotides Internally Labeled with Peptides Show Improved Target Recognition and Stability to Enzymatic Degradation.
Taskova M; Madsen CS; Jensen KJ; Hansen LH; Vester B; Astakhova K
Bioconjug Chem; 2017 Mar; 28(3):768-774. PubMed ID: 28292178
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic Cancer Gene Therapy Delivered by Nanoparticles.
Kurtanich T; Roos N; Wang G; Yang J; Wang A; Chung EJ
SLAS Technol; 2019 Apr; 24(2):151-160. PubMed ID: 30395768
[TBL] [Abstract][Full Text] [Related]
7. Efficient Tandem Copper-Catalyzed Click Synthesis of Multisugar-Modified Oligonucleotides.
Tölke AJ; Gaisbauer JF; Gärtner YV; Steigenberger B; Holovan A; Streshnev F; Schneider S; Müller M; Carell T
Angew Chem Int Ed Engl; 2024 Jun; 63(25):e202405161. PubMed ID: 38606873
[TBL] [Abstract][Full Text] [Related]
8. Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug.
Debacker AJ; Voutila J; Catley M; Blakey D; Habib N
Mol Ther; 2020 Aug; 28(8):1759-1771. PubMed ID: 32592692
[TBL] [Abstract][Full Text] [Related]
9. Click nucleic acid ligation: applications in biology and nanotechnology.
El-Sagheer AH; Brown T
Acc Chem Res; 2012 Aug; 45(8):1258-67. PubMed ID: 22439702
[TBL] [Abstract][Full Text] [Related]
10. Liver as a target for oligonucleotide therapeutics.
Sehgal A; Vaishnaw A; Fitzgerald K
J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
[TBL] [Abstract][Full Text] [Related]
11. RNA Interference Nanotherapeutics for Treatment of Glioblastoma Multiforme.
Singh P; Singh A; Shah S; Vataliya J; Mittal A; Chitkara D
Mol Pharm; 2020 Nov; 17(11):4040-4066. PubMed ID: 32902291
[TBL] [Abstract][Full Text] [Related]
12. Bioconjugates for targeted delivery of therapeutic oligonucleotides.
Ming X; Laing B
Adv Drug Deliv Rev; 2015 Jun; 87():81-9. PubMed ID: 25689735
[TBL] [Abstract][Full Text] [Related]
13. Clinical potential of oligonucleotide-based therapeutics in the respiratory system.
Moschos SA; Usher L; Lindsay MA
Pharmacol Ther; 2017 Jan; 169():83-103. PubMed ID: 27771436
[TBL] [Abstract][Full Text] [Related]
14. Overcoming cellular barriers for RNA therapeutics.
Dowdy SF
Nat Biotechnol; 2017 Mar; 35(3):222-229. PubMed ID: 28244992
[TBL] [Abstract][Full Text] [Related]
15. Targeted TFO delivery to hepatic stellate cells.
Yang N; Singh S; Mahato RI
J Control Release; 2011 Oct; 155(2):326-30. PubMed ID: 21763370
[TBL] [Abstract][Full Text] [Related]
16. Molecular dynamics simulation and binding energy calculation for estimation of oligonucleotide duplex thermostability in RNA-based therapeutics.
Shen L; Johnson TL; Clugston S; Huang H; Butenhof KJ; Stanton RV
J Chem Inf Model; 2011 Aug; 51(8):1957-65. PubMed ID: 21702481
[TBL] [Abstract][Full Text] [Related]
17. Cellular Delivery of RNA Nanoparticles.
Parlea L; Puri A; Kasprzak W; Bindewald E; Zakrevsky P; Satterwhite E; Joseph K; Afonin KA; Shapiro BA
ACS Comb Sci; 2016 Sep; 18(9):527-47. PubMed ID: 27509068
[TBL] [Abstract][Full Text] [Related]
18. Delivery of oligonucleotide-based therapeutics: challenges and opportunities.
Hammond SM; Aartsma-Rus A; Alves S; Borgos SE; Buijsen RAM; Collin RWJ; Covello G; Denti MA; Desviat LR; Echevarría L; Foged C; Gaina G; Garanto A; Goyenvalle AT; Guzowska M; Holodnuka I; Jones DR; Krause S; Lehto T; Montolio M; Van Roon-Mom W; Arechavala-Gomeza V
EMBO Mol Med; 2021 Apr; 13(4):e13243. PubMed ID: 33821570
[TBL] [Abstract][Full Text] [Related]
19. Ultramild protein-mediated click chemistry creates efficient oligonucleotide probes for targeting and detecting nucleic acids.
Nåbo LJ; Madsen CS; Jensen KJ; Kongsted J; Astakhova K
Chembiochem; 2015 May; 16(8):1163-7. PubMed ID: 25940911
[TBL] [Abstract][Full Text] [Related]
20. Solid-phase synthesis of oligonucleotide conjugates useful for delivery and targeting of potential nucleic acid therapeutics.
Lönnberg H
Bioconjug Chem; 2009 Jun; 20(6):1065-94. PubMed ID: 19175328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
